Cover Image

Real‐world data show sustained therapeutic effects of dupilumab in chronic rhinosinusitis with nasal polyps (CRSwNP) over 3 years

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Patrick Huber, Ulrike Förster‐Ruhrmann, Heidi Olze, Sven Becker, Friederike Bärhold, Mandy Cuevas, Nadine Gunder, Jan Hagemann, Christoph Matthias, Ludger Klimek, Moritz Gröger
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Allergy
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

More than half of chronic rhinosinusitis with nasal polyps (CRSwNP) patients treated with dupilumab experience early and fast olfactory improvement within 28 days
by: Josje Janna Otten, et al.
Published: (2024)

Perioperative adjuvant therapy with short course of dupilumab with ESS for recurrent CRSwNP
by: Audrey Pelletier, et al.
Published: (2024)

Real‐world predictors of dupilumab prescription in patients with chronic rhinosinusitis with nasal polyps
by: Christina Dorismond, et al.
Published: (2024)

Assessing adequacy of surgical extent in CRSwNP: The Completion of Surgery Index
by: Alan D. Workman, et al.
Published: (2024)

Early Olfactory Recovery With Tezepelumab in CRSwNP: Mechanistic and Clinical Considerations
by: Sushma Narsing Katkuri, et al.
Published: (2026)

Psychological Impact of Biologic Therapy in CRSwNP: A Pilot Study
by: Alessandro Maselli del Giudice, et al.
Published: (2025)

Contemporary practice patterns for chronic rhinosinusitis with nasal polyps
by: Noel F. Ayoub, et al.
Published: (2024)

Fluctuation of tissue eosinophils in chronic rhinosinusitis with nasal polyp
by: Kunjira Sombutpiboonphon, et al.
Published: (2024)

On the Interpretation of Long‐Term Outcomes After Combined FESS and Mepolizumab in Severe CRSwNP
by: Francesca Pirola, et al.
Published: (2026)

Dosing Interval Extension of Dupilumab in CRSwNP: Five‐Year Real World Outcomes
by: Nicholas J. Campion, et al.
Published: (2026)

Comparative Transcriptomic Analysis of Eosinophilic Chronic Rhinosinusitis With Nasal Polyps ( CRSwNP ) Using Nasal Tissue and Brushing Samples
by: Daiki Nakashima, et al.
Published: (2026)

Correction to “Dosing Interval Extension of Dupilumab in CRSwNP: Five‐Year Real World Outcomes”
Published: (2026)

Chronic rhinosinusitis with nasal polyps: Key considerations in the multidisciplinary team approach
by: Oliver Pfaar, et al.
Published: (2025)

Letter to the Editor Regarding “Perioperative Adjuvant Therapy With Short Course of Dupilumab With ESS for Recurrent CRSwNP”
by: Steven Chun‐Kang Liao, et al.
Published: (2025)

Optimal Timing of Dupilumab Application in CRSwNP: Impact of “Neoadjuvant Therapy” on Surgical Outcomes at 1 Year
by: Weiqing Wang, et al.
Published: (2025)

BDNF as a Key Mediator in Eosinophilic Inflammation in CRSwNP: Insights From Transcriptomic and Functional Analysis
by: Qinqin Zhang, et al.
Published: (2025)

Histopathologic evaluation of Asian‐American patients with chronic rhinosinusitis with nasal polyps
by: Arthur W. Wu, et al.
Published: (2024)

Dupilumab Improves Clinical Symptoms and Biomarkers in Comorbid Seasonal Timothy Grass Pollen Allergic Rhinitis in Patients With CRSwNP
by: Caroline Beutner, et al.
Published: (2024)

Type 1/17 CD103+CD4+ nasal‐resident memory T cells in non‐eosinophilic chronic rhinosinusitis with nasal polyps
by: Min‐Seok Rha, et al.
Published: (2024)

Letter to the Editor Regarding: “Assessing Adequacy of Surgical Extent in CRSwNP: The Completion of Surgery Index (CoSI)”
by: Daniel Spielman
Published: (2025)

Predictors of revision endoscopic sinus surgery in Finnish patients with chronic rhinosinusitis with nasal polyps
by: Sanna Toppila‐Salmi, et al.
Published: (2025)

WITHDRAWN: Glucocorticoids ameliorate periostin‐induced tissue remodeling in chronic rhinosinusitis with nasal polyps
Published: (2024)

Correlation between inflammatory biomarkers and disease control in chronic rhinosinusitis with nasal polyps
by: Eugenio De Corso, et al.
Published: (2024)

The Global Airways in Practice: Long‐term Effects of Mepolizumab With or Without FESS on Type 2 Inflammation in Patients With CRSwNP
by: Jens Tidemandsen, et al.
Published: (2025)

Benralizumab and the integrated management of co‐morbid severe eosinophilic asthma with chronic rhinosinusitis with nasal polyps
by: Joaquim Mullol, et al.
Published: (2025)

Associations of tenascin C with Th2 response, edema degree, and disease severity in patients with chronic rhinosinusitis with nasal polyps
by: Min Wang, et al.
Published: (2024)

Tissue‐specific early and late activated lymphocytes immunophenotype in chronic rhinosinusitis with nasal polyps
by: Soledad López‐Enríquez, et al.
Published: (2024)

Functional Endoscopic Sinus Surgery in Adults With CRSwNP Treated With Mepolizumab: Airway Physiology Outcomes From a Randomised Controlled Trial
by: Jens Tidemandsen, et al.
Published: (2026)

Probabilistic Sensitivity and Net Benefit Reporting in the Cost–Utility Comparison of EDS‐Fluticasone versus Budesonide Irrigation for Postoperative CRSwNP
by: Wei‐Zhe Hong
Published: (2026)

Risk factors investigation for different outcomes between unilateral and bilateral chronic rhinosinusitis with nasal polyps patients
by: Jianwei Wang, et al.
Published: (2024)

Topical steroids for chronic rhinosinusitis without nasal polyps: A systematic review and meta‐analysis
by: Akash M. Bhat, et al.
Published: (2024)

Response to “Probabilistic Sensitivity and Net Benefit Reporting in the Cost–Utility Comparison of EDS‐Fluticasone Versus Budesonide Irrigation for Postoperative CRSwNP ”
by: Daniel Xiao, et al.
Published: (2026)

Orthonasal and retronasal olfactory function in patients with chronic rhinosinusitis without nasal polyps undergoing endoscopic sinonasal surgery
by: Paolo Boscolo‐Rizzo, et al.
Published: (2024)

Omalizumab improves sleep and health status for patients with chronic rhinosinusitis with nasal polyps: An analysis of randomized clinical trials
by: Eli O. Meltzer, et al.
Published: (2024)

Rate of dupilumab use and symptom severity of patients with chronic rhinosinusitis with nasal polyposis after Draf 3 frontal sinusotomy
by: Keven Ji, et al.
Published: (2024)

Delayed neutrophil shedding of CD62L in patients with chronic rhinosinusitis with nasal polyps and asthma: Implications for Staphylococcus aureus colonization and corticosteroid treatment
by: Maryam Jafari, et al.
Published: (2024)

Differential modulation of allergic rhinitis nasal transcriptome by dupilumab and allergy immunotherapy
by: Matthew F. Wipperman, et al.
Published: (2024)

Increased SERPINB2 potentiates 15LO1 expression via STAT6 signalling in epithelial cells in eosinophilic chronic rhinosinusitis with nasal polyps
by: Chunyu Luo, et al.
Published: (2024)

Improved quality of life in patients with chronic rhinosinusitis with nasal polyps associated with expanded types of endoscopic sinus surgery: A 2‐year retrospective study
by: Daniel I Martin‐Jimenez, et al.
Published: (2024)

Dupilumab efficacy across serum IgE and blood eosinophil levels in chronic rhinosinusitis with nasal polyposis
by: Claus Bachert, et al.
Published: (2024)